{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:55:30Z","timestamp":1769518530059,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00784-020-03585-x","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T22:02:56Z","timestamp":1600898576000},"page":"2705-2716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Morphological and immunohistochemical features of tooth extraction sites in rats treated with alendronate, raloxifene, or strontium ranelate"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5119-7347","authenticated-orcid":false,"given":"Valesca Sander","family":"Koth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Gon\u00e7alves","family":"Salum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonia Zancanaro","family":"de Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Cherubini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"3585_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F, American Association of Oral and Maxillofacial Surgeons (2014) American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw - 2014 update. J Oral Maxillofac Surg 72:1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"key":"3585_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00774-019-01035-7","volume":"38","author":"S Hayashida","year":"2020","unstructured":"Hayashida S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Kojima Y, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakahara H, Shinohara M, Kondo E, Kurita H, Umeda M (2020) Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw. J Bone Miner Metab 38:126\u2013134. https:\/\/doi.org\/10.1007\/s00774-019-01035-7","journal-title":"J Bone Miner Metab"},{"key":"3585_CR3","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jcms.2015.08.008","volume":"43","author":"M Zandi","year":"2015","unstructured":"Zandi M, Dehghan A, Ghadermazi K, Malekzadeha H, Akbarzadeh M (2015) Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats. J Cranio-Maxillofac Surg 43:1823\u20131828. https:\/\/doi.org\/10.1016\/j.jcms.2015.08.008","journal-title":"J Cranio-Maxillofac Surg"},{"key":"3585_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00784-017-2325-6","volume":"22","author":"L Ramaglia","year":"2018","unstructured":"Ramaglia L, Guida A, Iorio-Siciliano V, Cuozzo A, Blasi A, Sculean A (2018) Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol. Clin Oral Investig 22:597\u2013615. https:\/\/doi.org\/10.1007\/s00784-017-2325-6","journal-title":"Clin Oral Investig"},{"key":"3585_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2017.00803","volume":"8","author":"V Pavone","year":"2017","unstructured":"Pavone V, Testa G, Giardina SMC, Andrea V, Domenico AR, Giuseppe S (2017) Pharmacological therapy of osteoporosis: a systematic current review of literature. Front Pharmacol 8:1\u20137. https:\/\/doi.org\/10.3389\/fphar.2017.00803","journal-title":"Front Pharmacol"},{"key":"3585_CR6","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00784-018-2349-6","volume":"22","author":"J Jung","year":"2018","unstructured":"Jung J, Park JS, Righesso L, Pabst AM, al-Nawas B, Kwon YD, Walter C (2018) Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro. Clin Oral Investig 22:2527\u20132534. https:\/\/doi.org\/10.1007\/s00784-018-2349-6","journal-title":"Clin Oral Investig"},{"key":"3585_CR7","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/bcp.13867","volume":"85","author":"S Cremers","year":"2019","unstructured":"Cremers S, Drake MT, Ebetino FH, Bilezikian JP, Russell RGG (2019) Pharmacology of bisphosphonates. Br J Clin Pharmacol 85:1052\u20131062. https:\/\/doi.org\/10.1111\/bcp.13867","journal-title":"Br J Clin Pharmacol"},{"key":"3585_CR8","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359\u20132381. https:\/\/doi.org\/10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"},{"key":"3585_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1210\/clinem\/dgaa048","volume":"105","author":"D Shoback","year":"2020","unstructured":"Shoback D, Rosen CJ, Black DM, Cheung AM, Murad MH, Eastell R (2020) Pharmacological management of osteoporosis in postmenopausal women: an endocrine society guideline update. J Clin Endocrinol Metab 105:587\u2013594. https:\/\/doi.org\/10.1210\/clinem\/dgaa048","journal-title":"J Clin Endocrinol Metab"},{"key":"3585_CR10","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.4317\/medoral.23324","volume":"25","author":"A Limones","year":"2020","unstructured":"Limones A, S\u00e1ez-Alcaide LM, D\u00edaz-Parre\u00f1o SA, Helm A, Bornstein MM, Molinero-Mourelle P (2020) Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: a systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal 25:e326\u2013e336. https:\/\/doi.org\/10.4317\/medoral.23324","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"3585_CR11","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1016\/j.ajpath.2014.07.010","volume":"184","author":"DW Williams","year":"2014","unstructured":"Williams DW, Lee C, Kim T, Yagita H, Wu H, Park S, Yang P, Liu H, Shi S, Shin KH, Kang MK, Park NH, Kim RH (2014) Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-\u03baB ligand antibody in mice. Am J Pathol 184:3084\u20133093. https:\/\/doi.org\/10.1016\/j.ajpath.2014.07.010","journal-title":"Am J Pathol"},{"key":"3585_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3290\/j.qi.a32918","volume":"46","author":"DA Baur","year":"2015","unstructured":"Baur DA, Altay MA, Teich S, Oswald SM, Quereshy FA (2015) Osteonecrosis of the jaw in a patient on raloxifene: a case report. Quintessence Int 46:423\u2013428. https:\/\/doi.org\/10.3290\/j.qi.a32918","journal-title":"Quintessence Int"},{"key":"3585_CR13","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1210\/jc.2013-4119","volume":"99","author":"WY Chiu","year":"2014","unstructured":"Chiu WY, Chien JY, Yang WS, Juang JJM, Lee JJ, Tsai KS (2014) The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate or raloxifene. J Clin Endocrinol Metab 99:2729\u20132735. https:\/\/doi.org\/10.1210\/jc.2013-4119","journal-title":"J Clin Endocrinol Metab"},{"key":"3585_CR14","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1097\/SCS.0000000000004278","volume":"29","author":"HA Rebelo Pontes","year":"2018","unstructured":"Rebelo Pontes HA, de Souza LL, Colares Uch\u00f4a DC, Mendes Cerqueira JM (2018) Mandibular osteonecrosis associated with raloxifene. J Craniofac Surg 29:e257\u2013e259. https:\/\/doi.org\/10.1097\/SCS.0000000000004278","journal-title":"J Craniofac Surg"},{"key":"3585_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.11138\/ccmbm\/2013.10.2.139","volume":"10","author":"L Longato","year":"2013","unstructured":"Longato L, Cavalli L, Marcucci G et al (2013) Osteonecrosis of the jaw in a patient with rheumatoid arthritis treated with an oral aminobisphosphonate: a clinical case report. Clin Cases Miner Bone Metab 10:139\u2013141. https:\/\/doi.org\/10.11138\/ccmbm\/2013.10.2.139","journal-title":"Clin Cases Miner Bone Metab"},{"key":"3585_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/039463201202500138","volume":"25","author":"A Notarnicola","year":"2012","unstructured":"Notarnicola A, Lisi S, Sisto M, de Marino AV, D'Amore M (2012) Possible role of oral ibandronate administration in osteonecrosis of the jaw: A case report. Int J Immunopathol Pharmacol 25:311\u2013316. https:\/\/doi.org\/10.1177\/039463201202500138","journal-title":"Int J Immunopathol Pharmacol"},{"key":"3585_CR17","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2147\/CIA.S141753","volume":"12","author":"WL Pan","year":"2017","unstructured":"Pan WL, Chen PL, Lin CY, Pan YC, Ju YR, Chan CP, Hsu RW (2017) Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: A case report. Clin Interv Aging 12:1089\u20131093. https:\/\/doi.org\/10.2147\/CIA.S141753","journal-title":"Clin Interv Aging"},{"key":"3585_CR18","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.bjoms.2015.08.006","volume":"53","author":"I Rahim","year":"2015","unstructured":"Rahim I, Salt S, Heliotis M (2015) Successful long-term mandibular reconstruction and rehabilitation using non-vascularised autologous bone graft and recombinant human BMP-7 with subsequent endosseous implant in a patient with bisphosphonate-related osteonecrosis of the jaw. Br J Oral Maxillofac Surg 53:870\u2013874. https:\/\/doi.org\/10.1016\/j.bjoms.2015.08.006","journal-title":"Br J Oral Maxillofac Surg"},{"key":"3585_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1533033819867354","volume":"18","author":"I Chattopadhyay","year":"2019","unstructured":"Chattopadhyay I, Verma M, Panda M (2019) Role of oral microbiome signatures in diagnosis and prognosis of oral cancer. Technol Cancer Res Treat 18:1\u201319. https:\/\/doi.org\/10.1177\/1533033819867354","journal-title":"Technol Cancer Res Treat"},{"key":"3585_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S8756-3282(01)00419-7","volume":"28","author":"SG Dahl","year":"2001","unstructured":"Dahl SG, Allain P, Marie PJ, Mauras Y, Boivin G, Ammann P, Tsouderos Y, Delmas PD, Christiansen C (2001) Incorporation and distribution of strontium in bone. Bone 28:446\u2013453. https:\/\/doi.org\/10.1016\/S8756-3282(01)00419-7","journal-title":"Bone"},{"key":"3585_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.pharmthera.2012.07.009","volume":"136","author":"Z Saidak","year":"2012","unstructured":"Saidak Z, Marie PJ (2012) Strontium signaling: molecular mechanisms and therapeutic implications in osteoporosis. Pharmacol Ther 136:216\u2013226. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.009","journal-title":"Pharmacol Ther"},{"key":"3585_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/1874325000903010014","volume":"3","author":"JRC Rey","year":"2009","unstructured":"Rey JRC, Cervino EV, Rentero ML, Crespo EC, \u00c1lvaro AO, Marta CM (2009) Raloxifene: mechanism of action, effects on bone tissue, and applicability in clinical traumatology practice. Open Orthop J 3:14\u201321. https:\/\/doi.org\/10.2174\/1874325000903010014","journal-title":"Open Orthop J"},{"key":"3585_CR23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2165\/00002018-200528080-00006","volume":"28","author":"A Cranney","year":"2005","unstructured":"Cranney A, Adachi JD (2005) Benefit-risk assessment of raloxifene in postmenopausal osteoporosis. Drug Saf 28:721\u2013730. https:\/\/doi.org\/10.2165\/00002018-200528080-00006","journal-title":"Drug Saf"},{"key":"3585_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: The arrive guidelines for reporting animal research. PLoS Biol 8:6\u201310. https:\/\/doi.org\/10.1371\/journal.pbio.1000412","journal-title":"PLoS Biol"},{"key":"3585_CR25","volume-title":"Guide for the care and use of laboratory animals","author":"E Edition","year":"2010","unstructured":"Edition E (2010) Guide for the care and use of laboratory animals, 8th edn. The national academies press, Washington DC","edition":"8"},{"key":"3585_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/hed.23260","volume":"36","author":"SA Berti-Couto","year":"2014","unstructured":"Berti-Couto SA, Vasconcelos ACU, Iglesias JE, Figueiredo MAZ, Salum FG, Cherubini K (2014) Diabetes mellitus and corticotherapy as risk factors for alendronate-related osteonecrosis of the jaws: A study in Wistar rats. Head Neck 36:84\u201393. https:\/\/doi.org\/10.1002\/hed.23260","journal-title":"Head Neck"},{"key":"3585_CR27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.bone.2009.12.016","volume":"46","author":"ER Luvizuto","year":"2010","unstructured":"Luvizuto ER, Dias SMD, Queiroz TP, Okamoto T, Garcia IR Jr, Okamoto R, Dornelles RCM (2010) Osteocalcin immunolabeling during the alveolar healing process in ovariectomized rats treated with estrogen or raloxifene. Bone 46:1021\u20131029. https:\/\/doi.org\/10.1016\/j.bone.2009.12.016","journal-title":"Bone"},{"key":"3585_CR28","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00198-008-0815-8","volume":"20","author":"SD Bain","year":"2009","unstructured":"Bain SD, Jerome C, Shen V, Dupin-Roger I, Ammann P (2009) Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants. Osteoporos Int 20:1417\u20131428. https:\/\/doi.org\/10.1007\/s00198-008-0815-8","journal-title":"Osteoporos Int"},{"key":"3585_CR29","doi-asserted-by":"publisher","unstructured":"Silva ML, Tasso L, Azambuja AA, Figueiredo MA, Salum FG, Silva VD, Cherubini K (2017) Effect of hyperbaric oxygen therapy on tooth extraction sites in rats subjected to bisphosphonate therapy\u2014histomorphometric and immunohistochemical analysis. Clin Oral Investig:21\u2013210. https:\/\/doi.org\/10.1007\/s00784-016-1778-3","DOI":"10.1007\/s00784-016-1778-3"},{"key":"3585_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/hed.21422","volume":"33","author":"MP Maahs","year":"2011","unstructured":"Maahs MP, Azambuja AA, Campos MM, Salum FG, Cherubini K (2011) Association between bisphosphonates and jaw osteonecrosis: A study in Wistar rats. Head Neck 33:199\u2013207. https:\/\/doi.org\/10.1002\/hed.21422","journal-title":"Head Neck"},{"key":"3585_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/002367797780600297","volume":"31","author":"B Close","year":"1997","unstructured":"Close B, Banister K, Baumans V, Bernoth EM, Bromage N, Bunyan J, Erhardt W, Flecknell P, Gregory N, Hackbarth H, Morton D, Warwick C (1997) Recommendations for euthanasia of experimental animals: Part 2. Lab Anim 31:1\u201332. https:\/\/doi.org\/10.1258\/002367797780600297","journal-title":"Lab Anim"},{"key":"3585_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2018.00505","volume":"9","author":"SK Ramchand","year":"2018","unstructured":"Ramchand SK, Seeman E (2018) Advances and unmet needs in the therapeutics of bone fragility. Front Endocrinol (Lausanne) 9:1\u201310. https:\/\/doi.org\/10.3389\/fendo.2018.00505","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3585_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","volume":"49","author":"MR Allen","year":"2011","unstructured":"Allen MR, Burr DB (2011) Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don\u2019t know. Bone 49:56\u201365. https:\/\/doi.org\/10.1016\/j.bone.2010.10.159","journal-title":"Bone"},{"key":"3585_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00784-009-0300-6","volume":"14","author":"S Hoefert","year":"2010","unstructured":"Hoefert S, Schmitz I, Tannapfel A, Eufinger H (2010) Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clin Oral Investig 14:271\u2013284. https:\/\/doi.org\/10.1007\/s00784-009-0300-6","journal-title":"Clin Oral Investig"},{"key":"3585_CR35","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00784-016-1718-2","volume":"20","author":"JW Kim","year":"2016","unstructured":"Kim JW, Landayan MEA, Lee JY, Tatad JCI, Kim SJ, Kim MR, Cha IH (2016) Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw. Clin Oral Investig 20:2251\u20132258. https:\/\/doi.org\/10.1007\/s00784-016-1718-2","journal-title":"Clin Oral Investig"},{"key":"3585_CR36","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00774-019-00990-5","volume":"37","author":"A Taguchi","year":"2019","unstructured":"Taguchi A, Uemura Y, Imai T et al (2019) Incidence of osteonecrosis of the jaw in Japanese osteoporosis patients taking minodronic acid. J Bone Miner Metab 37:886\u2013892. https:\/\/doi.org\/10.1007\/s00774-019-00990-5","journal-title":"J Bone Miner Metab"},{"key":"3585_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0196419","volume":"13","author":"WY Chiu","year":"2018","unstructured":"Chiu WY, Yang WS, Chien JY, Lee JJ, Tsai KS (2018) The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects. PLoS One 13:1\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0196419","journal-title":"PLoS One"},{"key":"3585_CR38","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.joms.2012.12.005","volume":"71","author":"M Kos","year":"2013","unstructured":"Kos M, Junka A, Smutnicka D, Bartoszewicz M, Kurzynowski T, Gluza K (2013) Pamidronate enhances bacterial adhesion to bone hydroxyapatite. Another puzzle in the pathology of bisphosphonate-related osteonecrosis of the jaw? J Oral Maxillofac Surg 71:1010\u20131016. https:\/\/doi.org\/10.1016\/j.joms.2012.12.005","journal-title":"J Oral Maxillofac Surg"},{"key":"3585_CR39","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.archoralbio.2014.05.002","volume":"59","author":"RC Boff","year":"2014","unstructured":"Boff RC, Salum FG, Figueiredo MA, Cherubini K (2014) Important aspects regarding the role of microorganisms in bisphosphonate-related osteonecrosis of the jaws. Arch Oral Biol 59:790\u2013799. https:\/\/doi.org\/10.1016\/j.archoralbio.2014.05.002","journal-title":"Arch Oral Biol"},{"key":"3585_CR40","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/jop.12038","volume":"42","author":"S Schipmann","year":"2013","unstructured":"Schipmann S, Metzler P, R\u00f6ssle M, Zemann W, von Jackowski J, Obwegeser JA, Gr\u00e4tz KW, Jacobsen C (2013) Osteopathology associated with bone resorption inhibitors - Which role does Actinomyces play? A presentation of 51 cases with systematic review of the literature. J Oral Pathol Med 42:587\u2013593. https:\/\/doi.org\/10.1111\/jop.12038","journal-title":"J Oral Pathol Med"},{"key":"3585_CR41","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1089\/mdr.2016.0196","volume":"23","author":"MH Hussein","year":"2017","unstructured":"Hussein MH, Schneider EK, Elliott AG, Han M, Reyes-Ortega F, Morris F, Blaskovich MAT, Jasim R, Currie B, Mayo M, Baker M, Cooper MA, Li J, Velkov T (2017) From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative \u201csuperbugs\u201d Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators. Microb Drug Resist 23:640\u2013650. https:\/\/doi.org\/10.1089\/mdr.2016.0196","journal-title":"Microb Drug Resist"},{"key":"3585_CR42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijantimicag.2012.05.009","volume":"40","author":"SJ Ho Sui","year":"2012","unstructured":"Ho Sui SJ, Lo R, Fernandes AR, Caulfield MDG, Lerman JA, Xie L, Bourne PE, Baillie DL, Brinkman FSL (2012) Raloxifene attenuates Pseudomonas aeruginosa pyocyanin production and virulence. Int J Antimicrob Agents 40:246\u2013251. https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.05.009","journal-title":"Int J Antimicrob Agents"},{"key":"3585_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1746-160X-8-20","volume":"8","author":"N Conte-Neto","year":"2012","unstructured":"Conte-Neto N, Bastos A d S, Spolidorio LC, Marcantonio CRA, Marcantonio E Jr (2012) Long-term treatment with alendronate increases the surgical difficulty during simple exodontias - an in vivo observation in Holtzman rats. Head Face Med 8:1. https:\/\/doi.org\/10.1186\/1746-160X-8-20","journal-title":"Head Face Med"},{"key":"3585_CR44","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1007\/s00198-005-1848-x","volume":"16","author":"E Richer","year":"2005","unstructured":"Richer E, Lewis MA, Odvina CV, Vazquez MA, Smith BJ, Peterson RD, Poindexter JR, Antich PP, Pak CYC (2005) Reduction in normalized bone elasticity following long-term bisphosphonate treatment as measured by ultrasound critical angle reflectometry. Osteoporos Int 16:1384\u20131392. https:\/\/doi.org\/10.1007\/s00198-005-1848-x","journal-title":"Osteoporos Int"},{"key":"3585_CR45","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.bone.2009.11.019.Higher","volume":"46","author":"M Shahnazari","year":"2011","unstructured":"Shahnazari M, Yao W, Dai W et al (2011) Properties in aged rats. Bone 46:1267\u20131274. https:\/\/doi.org\/10.1016\/j.bone.2009.11.019.Higher","journal-title":"Bone"},{"key":"3585_CR46","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1054\/ijom.2002.0292","volume":"31","author":"H Devlin","year":"2002","unstructured":"Devlin H, Sloan P (2002) Early bone healing events in the human extraction socket. Int J Oral Maxillofac Surg 31:641\u2013645. https:\/\/doi.org\/10.1054\/ijom.2002.0292","journal-title":"Int J Oral Maxillofac Surg"},{"key":"3585_CR47","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00784-017-2194-z","volume":"22","author":"Y Lv","year":"2018","unstructured":"Lv Y, Zhang Z, Su Y, Yuan P, Ma W, Huang W, Xu P (2018) Healing of root and surrounding periodontium after root damage with miniscrew implants: a histomorphologic study in dogs. Clin Oral Investig 22:1103\u20131111. https:\/\/doi.org\/10.1007\/s00784-017-2194-z","journal-title":"Clin Oral Investig"},{"key":"3585_CR48","unstructured":"Ema (2014) European Medicines Agency recommends that Protelos \/ Osseor remain available but with further restrictions. 44:1\u20133"},{"key":"3585_CR49","doi-asserted-by":"publisher","unstructured":"Grosso A, Douglas I, Hingorani A, MacAllister R, Smeeth L (2008) Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions. Br J Clin Pharmacol 66. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03273.x","DOI":"10.1111\/j.1365-2125.2008.03273.x"},{"key":"3585_CR50","unstructured":"NICE (2020) National Institute for Health and Care Excellence. https:\/\/www.evidence.nhs.uk\/search?q=strontium-ranelate. Accessed 15 Jun 2020"},{"key":"3585_CR51","unstructured":"Royal Osteoporosis Society (2019) Strontium ranelate returns to the UK as an osteoporosis drug treatment. In: 04\/01\/2019. https:\/\/theros.org.uk\/information-and-support\/osteoporosis-treatment\/strontium-ranelate\/. Accessed 25 May 2020"},{"key":"3585_CR52","doi-asserted-by":"publisher","unstructured":"Ali MS, Berencsi K, Marinier K, Deltour N, Perez-Guthann S, Pedersen L, Rijnbeek P, Lapi F, Simonetti M, Reyes C, Van der Lei J, Sturkenboom M, Prieto-Alhambra D (2020) Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR Alliance. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-020-05580-0","DOI":"10.1007\/s00198-020-05580-0"},{"key":"3585_CR53","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00198-017-4308-5","volume":"29","author":"E Mart\u00edn-Merino","year":"2018","unstructured":"Mart\u00edn-Merino E, Petersen I, Hawley S, \u00c1lvarez-Gutierrez A, Khalid S, Llorente-Garcia A, Delmestri A, Javaid MK, Van Staa TP, Judge A, Cooper C, Prieto-Alhambra D (2018) Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK. Osteoporos Int 29:467\u2013478. https:\/\/doi.org\/10.1007\/s00198-017-4308-5","journal-title":"Osteoporos Int"},{"key":"3585_CR54","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.bone.2010.01.379","volume":"46","author":"L Ma\u00efmoun","year":"2010","unstructured":"Ma\u00efmoun L, Brennan TC, Badoud I, Dubois-Ferriere V, Rizzoli R, Ammann P (2010) Strontium ranelate improves implant osseointegration. Bone 46:1436\u20131441. https:\/\/doi.org\/10.1016\/j.bone.2010.01.379","journal-title":"Bone"},{"key":"3585_CR55","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1902\/jop.2016.160227","volume":"88","author":"NC Karakan","year":"2017","unstructured":"Karakan NC, Akp\u0131nar A, G\u00f6ze F, Poyraz \u00d6 (2017) Investigating the effects of systemically administered strontium ranelate on alveolar bone loss histomorphometrically and histopathologically on experimental periodontitis in rats. J Periodontol 88:e24\u2013e31. https:\/\/doi.org\/10.1902\/jop.2016.160227","journal-title":"J Periodontol"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-020-03585-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-020-03585-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-020-03585-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T01:24:51Z","timestamp":1632360291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-020-03585-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3585"],"URL":"https:\/\/doi.org\/10.1007\/s00784-020-03585-x","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Valesca Sander Koth declares that she has no conflict of interest. Fernanda Gon\u00e7alves Salum declares that she has no conflict of interest. Maria Antonia Zancanaro de Figueiredo declares that she has no conflict of interest. Karen Cherubini declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee on Animals Use of the Pontifical Catholic University of Rio Grande do Sul (PUCRS, protocol #7700). All applicable international, national, and institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}